SANUWAVE Health, Inc. (SNWV) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Sanuwave Health, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.678 -- 00:00:05.101 Hello, and welcome everyone joining today's SanuWave earnings call. 00:00:05.101 -- 00:00:08.464 At this time, all participants are in a listen-only mode. 00:00:08.464 -- 00:00:12.086 Later, you will have the opportunity to ask questions during the question and answer 00:00:12.086 -- 00:00:17.150 session. To register to ask a question at any time, please press star 1 on your 00:00:17.150 -- 00:00:21.333 telephone keypad. Please note this call is being recorded. 00:00:21.333 -- 00:00:24.259 We are standing by should you need any assistance. 00:00:24.259 -- 00:00:29.902 It is now my pleasure to turn the meeting over to Morgan Frank, Chairman and CEO of Sanywave. 00:00:29.902 -- 00:00:30.602 Please go ahead. 00:00:30.602 -- 00:00:35.685 Morgan Frank Thank you, Leslie. So, welcome to Sanywave's second 00:00:35.685 -- 00:00:40.828 quarter 2026 earnings call. Our Form 10-Q was filed with the SEC 00:00:40.828 -- 00:00:46.971 last night, along with our earnings release, and our updated presentation was made available 00:00:46.971 -- 00:00:51.762 on our website in the investor section. Please refer to that during the presentation. 00:00:51.762 -- 00:00:56.545 Joining on the call is Peter Sorensen, our CFO, and after the presentation, we will open 00:00:56.545 -- 00:00:58.887 the call to Q&A. 00:00:58.887 -- 00:01:03.370 Let me begin with the forward-looking statements and other disclosures. 00:01:03.370 -- 00:01:07.093 This call may contain forward-looking statements, such as statements relating to future 00:01:07.093 -- 00:01:12.116 financial results, production expectations, plans for future business development activities, 00:01:12.116 -- 00:01:16.743 and expectations regarding the impact of changes in reimbursement levels and tariff rat...